Observational study on the prognostic value of testosterone and adiposity in postmenopausal estrogen receptor positive breast cancer patients

被引：0
|
作者：
Elisabetta Venturelli
Annalisa Orenti
Aline S. C. Fabricio
Giulia Garrone
Roberto Agresti
Biagio Paolini
Chiara Bonini
Massimo Gion
Franco Berrino
Christine Desmedt
Danila Coradini
Elia Biganzoli
机构：
[1] Department of Research,Department of Diagnostic Pathology and Laboratory
[2] Fondazione IRCCS Istituto Nazionale dei Tumori,Breast Cancer Translational Research Laboratory, J. C. Heuson, Institut Jules Bordet
[3] Laboratory of Medical Statistics and Epidemiology,Unit of Medical Statistics, Biometry and Bioinformatics
[4] “Giulio A. Maccacaro”,undefined
[5] Department of Clinical Sciences and Community Health,undefined
[6] Regional Center for Biomarkers,undefined
[7] Department of Clinical Pathology and Transfusion Medicine,undefined
[8] Breast Surgery Unit,undefined
[9] Fondazione IRCCS Istituto Nazionale dei Tumori,undefined
[10] Fondazione IRCCS Istituto Nazionale dei Tumori,undefined
[11] Université Libre de Bruxelles,undefined
[12] Campus Cascina Rosa,undefined
[13] Fondazione IRCCS Istituto Nazionale Tumori,undefined
来源：
BMC Cancer | / 18卷
关键词：
Testosterone; Body mass index; Estrogen receptor; Postmenopausal women; Breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] PROGNOSTIC VALUE OF ESTROGEN AND PROLACTIN RECEPTOR ANALYSIS IN HUMAN-BREAST CANCER
    WASEDA, N
    KATO, Y
    IMURA, H
    KURATA, M
    JAPANESE JOURNAL OF CANCER RESEARCH, 1985, 76 (06): : 517 - 523
  • [42] VALIDATION OF PRO_10, A MULTIGENE PROGNOSTIC SIGNATURE, IN PATIENTS (PTS) WITH EARLY, ESTROGEN RECEPTOR POSITIVE (ER plus ) POSTMENOPAUSAL BREAST CANCER (BC)
    Moor, A. E.
    Guevara, C.
    Altermatt, H. J.
    Jaggi, R.
    Aebi, S.
    ANNALS OF ONCOLOGY, 2010, 21 : 80 - 80
  • [43] ESTROGEN-RECEPTOR PROTEIN OF BREAST-CANCER IN PATIENTS WITH POSITIVE NODES - HIGH RECURRENCE RATES IN THE POSTMENOPAUSAL ESTROGEN RECEPTOR-NEGATIVE GROUP
    KINNE, DW
    BUTLER, JA
    KIMMEL, M
    FLEHINGER, BJ
    MENENDEZBOTET, C
    SCHWARTZ, M
    ARCHIVES OF SURGERY, 1987, 122 (11) : 1303 - 1306
  • [44] Prognostic impact of progesterone receptor status in 3030 Chinese estrogen receptor positive early breast cancer patients.
    Song, Zhenchuan
    Yao, Nan
    Wang, Xinle
    Yang, Shan
    Song, Heng
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [45] Prognostic significance of estrogen receptor in hormone receptor-positive and HER2-positive breast cancer
    Hikichi, M.
    Ushimado, K.
    Ri, Y.
    Kobayashi, N.
    Utsumi, T.
    BREAST, 2017, 32 : S94 - S95
  • [46] Estrogen receptor α polymorphisms and postmenopausal breast cancer risk
    A. M. González-Zuloeta Ladd
    A. Arias Vásquez
    F. Rivadeneira
    C. Siemes
    A. Hofman
    B. H. Ch. Stricker
    H. A. P. Pols
    A. G. Uitterlinden
    C. M. van Duijn
    Breast Cancer Research and Treatment, 2008, 107 : 415 - 419
  • [47] Estrogen receptor α polymorphisms and postmenopausal breast cancer risk
    Ladd, A. M. Gonzalez-Zuloeta
    Vasquez, A. Arias
    Rivadeneira, F.
    Siemes, C.
    Hofman, A.
    Stricker, B. H. Ch.
    Pols, H. A. P.
    Uitterlinden, A. G.
    van Duijn, C. M.
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 107 (03) : 415 - 419
  • [48] Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women
    Tamimi, Rulla M.
    Hankinson, Susan E.
    Chen, Wendy Y.
    Rosner, Bernard
    Colditz, Graham A.
    ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (14) : 1483 - 1489
  • [49] Prognostic value of gene expression of p63 by microarray analysis in estrogen receptor positive and negative breast cancer
    Hanker, L. C.
    Karn, T.
    Rody, A.
    Ruckhaeberle, E.
    Solbach, C.
    Kaufmann, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [50] Prognostic value of Bcl-2 in two independent populations of estrogen receptor positive breast cancer patients treated with adjuvant endocrine therapy
    Larsen, Mathilde S.
    Bjerre, Karsten
    Giobbie-Hurder, Anita
    Laenkholm, Anne-Vibeke
    Henriksen, Katrine L.
    Ejlertsen, Bent
    Lykkesfeldt, Anne E.
    Rasmussen, Birgitte B.
    ACTA ONCOLOGICA, 2012, 51 (06) : 781 - 789
12345